Exploring the Association Between Intra‐Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma Patients

Documenti analoghi

• Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy
  di: Emiel Leegwater, et al.
  Pubblicazione: (2024)
• Optimal Trough Concentration of Tacrolimus in Pediatric Patients With Primary Nephrotic Syndrome
  di: Hui Wang, et al.
  Pubblicazione: (2024)
• Lower Dose‐Normalized Tacrolimus Exposure in CYP3A5 *6 vs. *3 Loss‐of‐Function Allele Carriers: A Longitudinal Retrospective Real‐World Study in Kidney Transplant Recipients
  di: Amar D. Levens, et al.
  Pubblicazione: (2025)
• A Genome‐Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early‐Stage Breast Cancer Patients
  di: Anabel Beatriz Sanchez‐Spitman, et al.
  Pubblicazione: (2024)
• Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment
  di: Nikki de Rouw, et al.
  Pubblicazione: (2025)